Jiangxi Yuanyu Technology Co., Ltd – Trademark Portfolio

Entity Type: 99

Jiangxi Yuanyu Technology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include BONUANCI. The owner is based in Jiangxi.

2st Floor, Building 3, No. 666 Chuangxin Avenue, Pharmaceutical Zone, Yaodu Science and Technology Industrial Park, Zhangshu City, Yichun City

Jiangxi 331200 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BONUANCI
BONUANCI
Registered 2025

Trademark Classifications

Jiangxi Yuanyu Technology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Jiangxi Yuanyu Technology Co., Ltd have?

Jiangxi Yuanyu Technology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Jiangxi Yuanyu Technology Co., Ltd file in?

Jiangxi Yuanyu Technology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Jiangxi Yuanyu Technology Co., Ltd's most well-known trademarks?

Jiangxi Yuanyu Technology Co., Ltd's registered trademark portfolio includes well-known marks such as BONUANCI. These are among 1 currently registered trademark in the portfolio.

What is Jiangxi Yuanyu Technology Co., Ltd's trademark registration success rate?

Jiangxi Yuanyu Technology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.